Neoadjuvant chemotherapy with high-dose Ifosfamide, high-dose methotrexate, cisplatin, and doxorubicin for patients with localized osteosarcoma of the extremity: a joint study by the Italian and Scandinavian Sarcoma Groups. (Q33369033)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Neoadjuvant chemotherapy with high-dose Ifosfamide, high-dose methotrexate, cisplatin, and doxorubicin for patients with localized osteosarcoma of the extremity: a joint study by the Italian and Scandinavian Sarcoma Groups. |
scientific article |
Statements
Neoadjuvant chemotherapy with high-dose Ifosfamide, high-dose methotrexate, cisplatin, and doxorubicin for patients with localized osteosarcoma of the extremity: a joint study by the Italian and Scandinavian Sarcoma Groups (English)
Stefano Ferrari
Sigbjorn Smeland
Mario Mercuri
Franco Bertoni
Thor A Alvegard
Rodolfo Capanna
Gabriella Bernini
Cristoph Müller
Amelia Tienghi
Thomas Wiebe
Alessandro Comandone
Tom Böhling
Adalberto Brach Del Prever
Otte Brosjö
Gaetano Bacci
Gunnar Saeter
Italian and Scandinavian Sarcoma Groups